Wednesday's HotCopper trends: Race RC220 doses, West Mits Qala study
Summary by themarketonline.com.au
1 Articles
1 Articles
Wednesday's HotCopper trends: Race RC220 doses, West Mits Qala study
Race Oncology (ASX:RAC) has captured the most attention on the HotCopper forums today after successfully – and safely – dosing its first patient with RC220 and RC220 in combination with doxorubicin. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more. The clinical-stage biopharma company flagged the milestone in its Q4 FY25 report today, where it…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium